Read Eva Garland Consulting’s monthly newsletters, where we share insights from across the non-dilutive funding landscape.

November 2024 Newsletter

EGC’s October newsletter announces the grand opening of our new location in Irvine, California, celebrates the success of our client, Xmark Labs, and…

October 2024 Newsletter

EGC’s October newsletter celebrates the success of our client, Dignify Therapeutics, and showcases our Fall Grant Webinar Series with two upcoming…

September 2024 Newsletter

EGC’s September newsletter celebrates the success of our client Merlin Therapeutics and showcases two upcoming webinars – “Entity Formation Overview”…

August 2024 Newsletter

This month we profile the success of MapHabit, a provider of personalized cognitive support for patients and caregivers. We also highlight our recent…

July 2024 Newsletter

Client highlight: nCap Technologies is redefining what is possible with its recent Phase I Small Business Innovation Research (SBIR) award from the…

June 2024 Newsletter

Congratulations to Jigsawdio! This innovative company is creating a multi-sensory engagement platform for people living with Alzheimer’s Disease.

May 2024 Newsletter

Client Highlights: Congratulations to Cellforma on their recent NIH Phase I SBIR award from the National Heart, Lung, and Brain Institute (NHLBI)!

April 2024 Newsletter

Client highlight: Congratulations to Cardiost, Inc, for being named one of only six 2023 NationalInstitute on Aging (NIA) Start-Up Challenge and…

March 2024 Newsletter

Client highlight: EGC congratulates our client, Compact Medical, who is revolutionizing a Respiratory Bag-Valve-Mask Resuscitator to address…

February 2024 Newsletter

EGC is pleased to assist our clients in securing and managing the funding they need to support their groundbreaking research and development.

January 2024 Newsletter

We thank our 3,000+ clients for the privilege of being part of your journey and are thrilled to share some highlights of 2023 and new opportunities…

Subscribe to our monthly newsletter, where we share insights from across the non-dilutive funding landscape.